Athenex Financials

Athenex Stock Summary

Athenex competes with Adverum Biotechnologies, and CytomX Therapeutics. Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York. Athenex operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.

Athenex Key Financial Ratios

Athenex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Athenex's current stock value. Our valuation model uses many indicators to compare Athenex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Athenex competition to find correlations between indicators driving Athenex's intrinsic value. More Info.Athenex is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Athenex's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

If you are still planning to invest in Athenex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athenex's history and understand the potential risks before investing.